About Bruker Corporation
https://www.bruker.comBruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
CEO
Frank H. Laukien
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 187
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
B of A Securities
Buy
Jefferies
Buy
Guggenheim
Buy
Wolfe Research
Outperform
Barclays
Overweight
JP Morgan
Overweight
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
ORBIS ALLAN GRAY LTD
Shares:14.15M
Value:$695.11M
FMR LLC
Shares:13.73M
Value:$674.83M
BLACKROCK, INC.
Shares:10.96M
Value:$538.44M
Summary
Showing Top 3 of 453
About Bruker Corporation
https://www.bruker.comBruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $860.5M ▲ | $319.3M ▼ | $-59.6M ▼ | -6.93% ▼ | $-0.41 ▼ | $3.1M ▼ |
| Q2-2025 | $797.4M ▼ | $346M ▼ | $7.6M ▼ | 0.95% ▼ | $0.05 ▼ | $72.3M ▼ |
| Q1-2025 | $801.4M ▼ | $359.4M ▼ | $17.4M ▲ | 2.17% ▲ | $0.11 ▲ | $88.6M ▼ |
| Q4-2024 | $979.6M ▲ | $421.2M ▲ | $13.7M ▼ | 1.4% ▼ | $0.09 ▼ | $124.6M ▲ |
| Q3-2024 | $864.4M | $350.7M | $40.9M | 4.73% | $0.27 | $117.9M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $295M ▲ | $6.43B ▲ | $3.94B ▼ | $2.43B ▲ |
| Q2-2025 | $92M ▼ | $6.34B ▲ | $4.47B ▲ | $1.8B ▼ |
| Q1-2025 | $184.2M ▲ | $5.93B ▲ | $4.08B ▲ | $1.82B ▲ |
| Q4-2024 | $183.4M ▲ | $5.81B ▼ | $3.99B ▼ | $1.78B ▼ |
| Q3-2024 | $148.1M | $6.11B | $4.27B | $1.81B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-58.5M ▼ | $-33.2M ▲ | $-23.8M ▲ | $258.4M ▲ | $201.1M ▲ | $-54.1M ▲ |
| Q2-2025 | $4.2M ▼ | $-127.5M ▼ | $-91.1M ▼ | $95.5M ▲ | $-91.5M ▼ | $-148.8M ▼ |
| Q1-2025 | $16.8M ▲ | $65M ▼ | $-26.1M ▲ | $-51.2M ▲ | $1M ▼ | $39M ▼ |
| Q4-2024 | $13.9M ▼ | $190M ▲ | $-60.6M ▲ | $-75M ▼ | $35M ▲ | $153.3M ▲ |
| Q3-2024 | $40.3M | $38.4M | $-67.6M | $-2.7M | $-21.5M | $5.8M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $810.00M ▲ | $640.00M ▼ | $630.00M ▼ | $690.00M ▲ |
 Product and Service Other | $170.00M ▲ | $160.00M ▼ | $160.00M ▲ | $170.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 AsiaPacific Excluding China | $0 ▲ | $0 ▲ | $130.00M ▲ | $130.00M ▲ |
 CHINA | $110.00M ▲ | $100.00M ▼ | $110.00M ▲ | $120.00M ▲ |
 Europe Excluding Germany | $0 ▲ | $0 ▲ | $210.00M ▲ | $240.00M ▲ |
 GERMANY | $90.00M ▲ | $60.00M ▼ | $60.00M ▲ | $70.00M ▲ |
 Other Country | $70.00M ▲ | $70.00M ▲ | $60.00M ▼ | $70.00M ▲ |
 Rest of Asia Pacific | $160.00M ▲ | $130.00M ▼ | $0 ▼ | $0 ▲ |
 Rest Of Europe | $290.00M ▲ | $220.00M ▼ | $0 ▼ | $0 ▲ |
 UNITED STATES | $260.00M ▲ | $220.00M ▼ | $220.00M ▲ | $230.00M ▲ |
CEO
Frank H. Laukien
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 187
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
B of A Securities
Buy
Jefferies
Buy
Guggenheim
Buy
Wolfe Research
Outperform
Barclays
Overweight
JP Morgan
Overweight
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
ORBIS ALLAN GRAY LTD
Shares:14.15M
Value:$695.11M
FMR LLC
Shares:13.73M
Value:$674.83M
BLACKROCK, INC.
Shares:10.96M
Value:$538.44M
Summary
Showing Top 3 of 453